• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用残基相互作用网络和配体竞争饱和法鉴定A类G蛋白偶联受体上的可成药结合位点

Exploring Druggable Binding Sites on the Class A GPCRs Using the Residue Interaction Network and Site Identification by Ligand Competitive Saturation.

作者信息

Inan Tugce, Yuce Merve, MacKerell Alexander D, Kurkcuoglu Ozge

机构信息

Department of Chemical Engineering, Istanbul Technical University, Istanbul 34469, Turkey.

Chemical Engineering Department, Faculty of Engineering & Architecture, Istanbul Beykent University, Istanbul 34396, Turkey.

出版信息

ACS Omega. 2024 Sep 13;9(38):40154-40171. doi: 10.1021/acsomega.4c06172. eCollection 2024 Sep 24.

DOI:10.1021/acsomega.4c06172
PMID:39346853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11425613/
Abstract

G protein-coupled receptors (GPCRs) play a central role in cellular signaling and are linked to many diseases. Accordingly, computational methods to explore potential allosteric sites for this class of proteins to facilitate the identification of potential modulators are needed. Importantly, the availability of rich structural data providing the locations of the orthosteric ligands and allosteric modulators targeting different GPCRs allows for the validation of approaches to identify new allosteric binding sites. Here, we validate the combination of two computational techniques, the residue interaction network (RIN) model and the site identification by ligand competitive saturation (SILCS) method, to predict putative allosteric binding sites of class A GPCRs. RIN analysis identifies hub residues that mediate allosteric signaling within a receptor and have a high capacity to alter receptor dynamics upon ligand binding. The known orthosteric (and allosteric) binding sites of 18 distinct class A GPCRs were successfully predicted by RIN through a dataset of 105 crystal structures (91 ligand-bound, 14 unbound) with up to 77.8% (76.9%) sensitivity, 92.5% (95.3%) specificity, 51.9% (50%) precision, and 86.2% (92.4%) accuracy based on the experimental and theoretical binding site data. Moreover, graph spectral analysis of the residue networks revealed that the proposed sites were located at the interfaces of highly interconnected residue clusters with a high ability to coordinate the functional dynamics. Then, we employed the SILCS-Hotspots method to assess the druggability of the novel sites predicted for 7 distinct class A GPCRs that are critical for a variety of diseases. While the known orthosteric and allosteric binding sites are successfully explored by our approach, numerous putative allosteric sites with the potential to bind drug-like molecules are proposed. The computational approach presented here promises to be a highly effective tool to predict putative allosteric sites of GPCRs to facilitate the design of effective modulators.

摘要

G蛋白偶联受体(GPCRs)在细胞信号传导中起着核心作用,并且与许多疾病相关。因此,需要计算方法来探索这类蛋白质的潜在变构位点,以促进潜在调节剂的识别。重要的是,丰富的结构数据提供了靶向不同GPCRs的正构配体和变构调节剂的位置,这使得验证识别新变构结合位点的方法成为可能。在此,我们验证了两种计算技术的组合,即残基相互作用网络(RIN)模型和配体竞争饱和法识别位点(SILCS)方法,以预测A类GPCRs的假定变构结合位点。RIN分析可识别介导受体变构信号传导且在配体结合后具有改变受体动力学高能力的枢纽残基。通过包含105个晶体结构(91个配体结合型、14个未结合型)的数据集,RIN成功预测了18种不同A类GPCRs的已知正构(和变构)结合位点,基于实验和理论结合位点数据,灵敏度高达77.8%(76.9%),特异性为92.5%(95.3%),精确率为51.9%(50%),准确率为86.2%(92.4%)。此外,对残基网络的图谱谱分析表明,所提出的位点位于高度互连的残基簇的界面处,具有协调功能动力学的高能力。然后,我们采用SILCS-热点方法评估了为7种对多种疾病至关重要的不同A类GPCRs预测的新位点的成药可能性。虽然我们的方法成功地探索了已知的正构和变构结合位点,但也提出了许多具有结合类药物分子潜力的假定变构位点。本文提出的计算方法有望成为预测GPCRs假定变构位点以促进有效调节剂设计的高效工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1298/11425613/ec963d4ec993/ao4c06172_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1298/11425613/3a7871e8e78a/ao4c06172_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1298/11425613/e24c69500915/ao4c06172_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1298/11425613/1b02f4c0a318/ao4c06172_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1298/11425613/d6190c1bdb11/ao4c06172_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1298/11425613/d748c18e393e/ao4c06172_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1298/11425613/a7b9b2efdf93/ao4c06172_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1298/11425613/b364cb0e25b2/ao4c06172_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1298/11425613/971ce064b8dd/ao4c06172_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1298/11425613/ec963d4ec993/ao4c06172_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1298/11425613/3a7871e8e78a/ao4c06172_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1298/11425613/e24c69500915/ao4c06172_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1298/11425613/1b02f4c0a318/ao4c06172_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1298/11425613/d6190c1bdb11/ao4c06172_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1298/11425613/d748c18e393e/ao4c06172_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1298/11425613/a7b9b2efdf93/ao4c06172_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1298/11425613/b364cb0e25b2/ao4c06172_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1298/11425613/971ce064b8dd/ao4c06172_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1298/11425613/ec963d4ec993/ao4c06172_0009.jpg

相似文献

1
Exploring Druggable Binding Sites on the Class A GPCRs Using the Residue Interaction Network and Site Identification by Ligand Competitive Saturation.利用残基相互作用网络和配体竞争饱和法鉴定A类G蛋白偶联受体上的可成药结合位点
ACS Omega. 2024 Sep 13;9(38):40154-40171. doi: 10.1021/acsomega.4c06172. eCollection 2024 Sep 24.
2
Identification and characterization of fragment binding sites for allosteric ligand design using the site identification by ligand competitive saturation hotspots approach (SILCS-Hotspots).使用配体竞争饱和热点法(SILCS-Hotspots)进行变构配体设计的片段结合位点的鉴定和特征描述。
Biochim Biophys Acta Gen Subj. 2020 Apr;1864(4):129519. doi: 10.1016/j.bbagen.2020.129519. Epub 2020 Jan 3.
3
Identifying and Assessing Putative Allosteric Sites and Modulators for CXCR4 Predicted through Network Modeling and Site Identification by Ligand Competitive Saturation.通过网络建模和配体竞争饱和鉴定预测 CXCR4 的潜在变构结合位点和调节剂。
J Phys Chem B. 2024 May 30;128(21):5157-5174. doi: 10.1021/acs.jpcb.4c00925. Epub 2024 Apr 22.
4
Application of Mixed-Solvent Molecular Dynamics Simulations for Prediction of Allosteric Sites on G Protein-Coupled Receptors.混合溶剂分子动力学模拟在 G 蛋白偶联受体变构位点预测中的应用。
Mol Pharmacol. 2023 May;103(5):274-285. doi: 10.1124/molpharm.122.000612. Epub 2023 Mar 3.
5
Annotation of Allosteric Compounds to Enhance Bioactivity Modeling for Class A GPCRs.别构化合物的注释以增强 A 类 GPCR 生物活性建模。
J Chem Inf Model. 2020 Oct 26;60(10):4664-4672. doi: 10.1021/acs.jcim.0c00695. Epub 2020 Oct 5.
6
Binding Characterization of GPCRs-Modulator by Molecular Complex Characterizing System (MCCS).用分子复合物特征系统(MCCS)对 GPCRs-调节剂的结合特性进行分析。
ACS Chem Neurosci. 2020 Oct 21;11(20):3333-3345. doi: 10.1021/acschemneuro.0c00457. Epub 2020 Oct 7.
7
Combined Physics- and Machine-Learning-Based Method to Identify Druggable Binding Sites Using SILCS-Hotspots.基于物理和机器学习的联合方法,利用 SILCS-Hotspots 识别可成药结合位点。
J Chem Inf Model. 2024 Oct 14;64(19):7743-7757. doi: 10.1021/acs.jcim.4c01189. Epub 2024 Sep 16.
8
Does the Lipid Bilayer Orchestrate Access and Binding of Ligands to Transmembrane Orthosteric/Allosteric Sites of G Protein-Coupled Receptors?脂质双层是否调控配体与 G 蛋白偶联受体跨膜正构/变构位点的结合和进入?
Mol Pharmacol. 2019 Nov;96(5):527-541. doi: 10.1124/mol.118.115113. Epub 2019 Apr 8.
9
Identification of Selective Novel Hits against Prolyl tRNA Synthetase Active Site and a Predicted Allosteric Site Using Approaches.使用 方法鉴定脯氨酰 tRNA 合成酶活性位点和预测的别构位点的选择性新型命中。
Int J Mol Sci. 2020 May 27;21(11):3803. doi: 10.3390/ijms21113803.
10
Unraveling GPCRs Allosteric Modulation. Cannabinoid 1 Receptor as a Case Study.解析G蛋白偶联受体的变构调节。以大麻素1受体为例进行研究。
Proteins. 2025 Apr;93(4):763-785. doi: 10.1002/prot.26762. Epub 2024 Nov 25.

引用本文的文献

1
[Research on prediction model of protein thermostability integrating graph embedding and network topology features].整合图嵌入与网络拓扑特征的蛋白质热稳定性预测模型研究
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2025 Aug 25;42(4):817-823. doi: 10.7507/1001-5515.202501045.
2
In Silico Identification of Putative Allosteric Pockets and Inhibitors for the KRASG13D-SOS1 Complex in Cancer Therapy.癌症治疗中KRASG13D-SOS1复合物假定变构口袋和抑制剂的计算机模拟鉴定
Int J Mol Sci. 2025 Apr 2;26(7):3293. doi: 10.3390/ijms26073293.
3
Detection of Putative Ligand Dissociation Pathways in Proteins Using Site-Identification by Ligand Competitive Saturation.

本文引用的文献

1
Combined Physics- and Machine-Learning-Based Method to Identify Druggable Binding Sites Using SILCS-Hotspots.基于物理和机器学习的联合方法,利用 SILCS-Hotspots 识别可成药结合位点。
J Chem Inf Model. 2024 Oct 14;64(19):7743-7757. doi: 10.1021/acs.jcim.4c01189. Epub 2024 Sep 16.
2
Reinforcing Tunnel Network Exploration in Proteins Using Gaussian Accelerated Molecular Dynamics.使用高斯加速分子动力学增强蛋白质中的隧道网络探索。
J Chem Inf Model. 2024 Aug 26;64(16):6623-6635. doi: 10.1021/acs.jcim.4c00966. Epub 2024 Aug 15.
3
Identifying and Assessing Putative Allosteric Sites and Modulators for CXCR4 Predicted through Network Modeling and Site Identification by Ligand Competitive Saturation.
利用配体竞争饱和法进行位点鉴定来检测蛋白质中假定的配体解离途径
J Chem Inf Model. 2025 Mar 24;65(6):3022-3034. doi: 10.1021/acs.jcim.4c01814. Epub 2024 Dec 27.
通过网络建模和配体竞争饱和鉴定预测 CXCR4 的潜在变构结合位点和调节剂。
J Phys Chem B. 2024 May 30;128(21):5157-5174. doi: 10.1021/acs.jpcb.4c00925. Epub 2024 Apr 22.
4
Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy.硝基苄叉氧吗啡酮,一种具有高μ阿片受体效能的双功能μ和δ阿片受体配体。
Front Pharmacol. 2023 Jul 3;14:1230053. doi: 10.3389/fphar.2023.1230053. eCollection 2023.
5
G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders.G 蛋白偶联受体在神经退行性疾病和精神障碍中的作用。
Signal Transduct Target Ther. 2023 May 3;8(1):177. doi: 10.1038/s41392-023-01427-2.
6
Predicting allosteric pockets in protein biological assemblages.预测蛋白质生物组装体中的变构口袋。
Bioinformatics. 2023 May 4;39(5). doi: 10.1093/bioinformatics/btad275.
7
Structures of the entire human opioid receptor family.人类阿片受体家族的结构。
Cell. 2023 Jan 19;186(2):413-427.e17. doi: 10.1016/j.cell.2022.12.026. Epub 2023 Jan 12.
8
In silico identification of a β-adrenoceptor allosteric site that selectively augments canonical βAR-Gs signaling and function.通过计算机筛选出一种β-肾上腺素能受体变构位点,该位点选择性增强经典βAR-Gs 信号转导和功能。
Proc Natl Acad Sci U S A. 2022 Dec 6;119(49):e2214024119. doi: 10.1073/pnas.2214024119. Epub 2022 Nov 30.
9
GPCRdb in 2023: state-specific structure models using AlphaFold2 and new ligand resources.2023 年的 GPCRdb:使用 AlphaFold2 和新配体资源的特定状态结构模型。
Nucleic Acids Res. 2023 Jan 6;51(D1):D395-D402. doi: 10.1093/nar/gkac1013.
10
Selective activation of Gαob by an adenosine A receptor agonist elicits analgesia without cardiorespiratory depression.腺苷 A 受体激动剂选择性激活 Gαob 可产生镇痛作用而不引起心肺抑制。
Nat Commun. 2022 Jul 18;13(1):4150. doi: 10.1038/s41467-022-31652-2.